Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Hepatocellular 2Ovarian Neoplasms 1Neoplasms 1Heart Failure 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Cardiotoxicity 1Breast Neoplasms 1

Interventions

Megestrol Acetate 5Tirzepatide 2Progestins 2Metformin 2Biopsy 2Atorvastatin 2exemestane 1estradiol, norethindrone drug combination 1Rosuvastatin Calcium 1Pterocarpus marsupium 1Progesterone 1Pharmacogenomic Variants 1Medroxyprogesterone Acetate 1Levonorgestrel 1Hysterectomy 1Hydroxymethylglutaryl-CoA Reductase Inhibitors 1Everolimus 1Curettage 13,5-dimethoxy-4'-hydroxystilbene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Endometrial Hyperplasia × Hydroxymethylglutaryl-CoA Reductase Inhibitors × Clear all
NCT06102863 2025-04-29

Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

Peking University People's Hospital

Phase 2 Recruiting
38 enrolled
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡